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Two hundred and ten patients with meningismus and the infections of the central nervous
system (CNS) with the clinical symptoms and signs of the acute serous meningitis syn-
drome, were divided in to groups according to etiology (enterovirus meningitis-ENTERO,
serous meningitis various etiology-SM and tuberculous meningitis-TBC). Intrathecal syn-
thesis (ITS) of C3c and C4 complement components and IgG were determined by the
method of cerebrospinal indexes (I), to examine their role in differential diagnosis of this
syndrome. Correlative study between the CSF/serum ratio (Q) for albumin (Alb) and
QC3c and QC4 in patients with no proven ITS of this two complement proteins, and the
comparative study of the increased value of C3cI and C4I (and IgGI) between the exam-
ined groups of the patients was done. Highly significant correlations were found between
QAlb and QC3c (r = 0.89, p<0.001) and QC4 (r = 0.85, p<0.001). In 22,4% of the ex-
amined patients ITS of C3c and C4 were found. There was no difference in frequency of
ITS of the two complement proteins between the examined groups, nor inside any par-
ticular group. TBC group had significantly lower (p<0.05) intensity of ITS of C3c and C4
than MNG and ENTERO, and significantly higher intensity of ITS of IgG (p<0.05) than
the other tested groups. CSF index was confirmed as a valid method to detect intrathecal
C3c and C4 production. Determination of ITS C3c and C4 could not be of great help in
differential diagnosis in the acute serous meningitis syndrome. The intensity of ITS of C3c
and C4, related to the intensity of ITS of IgG, could be of help in the determination of the
duration of the disease.
K e y   w o r d s :  meningitis; meningism; cerebrospinal fluid; cerebrospinal
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Introduction
The main mediator of humoral immunity and inflam-
mation is the complement system. It consists of nine pro-
teins and many of their proteolytic cleavage products with
important biologic effects like opsonization, activation of
inflammation and solubilization of immune complexes. The
final effect of the activation of this system was the destruc-
tion of microorganisms, but it might also have led to the
host tissue damage. According to the nature of the activa-
tor, this system was divided into classical, where the main
activators were immunoglobulins (Ig), and alternative,
which was activated in the absence of antibody; thus, this
pathway of complement activation plays a role in the natu-
ral immunity. Determination of complement components
C3c and C4 in serum was widely used in routine analysis
which covered both pathways of activation of this system.
There were no many systematic investigations of the
complement system in the cerebrospinal fluid (CSF) in
various neurological diseases, particularly in infections of
the central nervous system (CNS). The reasons were the
need for sufficiently precise methods for determinations ofStrana 266 VOJNOSANITETSKI PREGLED Broj 3
normally low concentrations of complement components
and their proteolytic products in CSF, difficulties in simul-
taneous determinations of various different components
and their derivatives in routine use and complexity of inter-
pretation of results in the light of the blood-brain barrier
(BBB), pathological process in CNS and in mutual influ-
ence of complement components.
In the last decade several reports particularly pointed
to the probability of diagnostic significance of the comple-
ment components determinations in CSF. It was shown that
CSF levels of C4d or C4d index had served as the basis for
differentiating progressive supranuclear paralisys from
Parkinson's disease (1), and that CSF levels of C4d had
served as a sensitive indicator for the radicular involvement
in demyelinating polyneuropathy (2). In one of the recent
reports it was found that intrathecal synthesis (ITS) of C3
or C4 contributed a little to the differential diagnosis of
immunological CNS disorders (multiple sclerosis, systemic
lupus erythematosus and human immunodeficiency virus
infection) (3).
Examinations of the complement components C3c
and C4 in CSF in inflammatory CNS diseases of infections
nature were restricted only to frequency presentation of
their activation and ITS (4, 5). We presumed that determi-
nation of C3c and C4 in CSF in the patients with CNS in-
fections, which covered the classical, as well as alternative
pathway of complement activation, could be of diagnostic
use, or could indirectly point to the nature of the activator.
To test this possibility, we measured the CSF and
plasma concentrations of C3c and C4 in patients with the
CNS infections with signs of the acute serous meningitis
syndrome, to show the activation and the production of this
two components of complement within the CSF compart-
ment and to examine whether there were any differences in
frequency and intensity of ITS of this two components of
complement, according to the etiology of disease.
Methods
Two hundred and ten patients were examined in this
study: 178 with infections of CNS with the clinical symptoms
and signs of the acute serous meningitis syndrome (ASM),
and 32 with meningismus which appeared during the acute
diseases of various etiology. Patients with the ASM syndrome
were divided into groups according to etiology, clinical pic-
ture, cytochemical findings in CSF and courses of the disease:
enterovirus meningitis (ENTERO, n  =  120), acute serous
meningitis of various, probably viral and nonviral etiology
(SM,  n = 44)  and  tuberculous  meningitis  (TBC,  n = 14).
Control group consisted of 59 patients (36 women and 23
men, aged 5−82 years) with clinical and laboratory findings
without objective signs of organic neurological diseases.
Peripheral venous blood and CSF were taken simulta-
neously in all examined patients according to standard pro-
cedures. Cytological analysis and total protein measure-
ments were done in fresh samples of CSF as a part of rou-
tine laboratory investigations, and part of CSF and serum
was stored at -70ˆC until assayed. The concentrations of
C3c, C4, albumin (Alb) and IgG were determined simulta-
neously by laser immunonephelometry (Behring laser Ne-
felometar) in unfrozen samples of CSF and serum. Serum
dilutions were adopted for CSF calibration curves (5, 6).
CSF/serum ratio (Q) for Alb (QAlb = Alb CSF/Alb se-
rum x 10
-3) was used as an indicator of BBB function, and the
CSF index (I) was used as an indicator of intrathecal synthesis
of IgG and complement components C3c and C4 (I = Q pro-
tein/QAlb) (7). The upper reference values were established
by the analysis of the control group: IgGI<0.7; C3cI<0.7; C4I
to 15 years <1.6; from 16 years <1.2; and the upper reference
values QAlb were determined according to Reiber (8) (to 15
years <5; from 16 years <6.5; from 40 years <8).
The Student's t-test and Mann-Whitney test were used
to compare the groups of patients and control group, and
the regression analysis was done to determine the signifi-
cance of correlations between various parameters.
Results
The concentrations of C3c and C4 (” and SD) in sera
of the patients with MNG and the syndrome of ASM are
shown in Fig. 1. All patients groups had significantly higher
mean concentrations of C4 (p<0.001), and significantly
lower mean concentrations of C3c (except ENTERO) in
serum (MNG, SM p<0.001; TBC p<0.001), compared to
the control group. Among the patients groups significantly
higher mean concentrations of C3c in serum were in
ENTERO than in MNG and SM groups (p<0.05), while
among the other groups there were no differences, which
were also not found for the mean concentrations of C4.
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Fig. 1 − Concentrations of the complement C3c and C4 in
sera of the patients with the syndrome of ASM, divided in
groups according to etiology of the disease (” „ SD)
Looking at C3c and C4 quotients (” and SD) (Fig. 2),
higher values of QC4 then QC3c were seen, as well as a
gradual increase in the values of the both Q from MNG to
ENTERO, SM to TBC group which had significantly higher
mean values of the both Q then the other groups (p<0.05),
among which there were no significant differences. Com-Broj 3 VOJNOSANITETSKI PREGLED Strana 267
pared to the control group, MNG group had significantly
lower values of QC3c and QC4, and significantly higher
TBC (p<0.05), while ENTERO group had significantly
lower value of QC4 (p<0.001), and SM significantly higher
value of QC3c (p<0.001).
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Fig. 2 − CSF/serum concentration ratios (Q) of the com-
plement C3c and C4 in the patients with the ASM syn-
drome, divided into groups according to the etiology of the
disease (” „ SD)
The values of QAlb are shown at the Fig. 3 (” and SD).
Here also the mean values of QAlb were increasing from
MNG, over the ENTERO, SM to TBC group. The signifi-
cantly higher mean values of QAlb were in TBC than in the
other groups (p<0.05), and the significantly lower mean val-
ues of QAlb had MNG comparing to ENTERO and SM
groups (p<0.05). In relation to the control group, MNG had
significantly lower, and SM and TBC groups significantly
higher values of QAlb (p<0.001), while among the ENTERO
and control group there were no significant differences.
In patients in whom the ITS of C3c and C4 was not
proved, the high positive correlation between QAlb and
QC3c  (r = 0.89,  p<0.001)  and QC4 (r  =  0.85, p<0.001)
was found.
The number and the percent of the patients in whom
ITS of C3c and C4 was proved is shown in Table l. ITS of
C3c and C4 was found in 22.4% of the examined patients.
Almost equal frequency of ITS of this two protein comple-
ments was found, and there were neither statistically sig-
nificant differences between the groups nor inside of the
particular group compared to the found combinations of
ITS of C3c and C4.
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Fig. 3 − CSF/serum concentration ratios (Q) of albumin in
the patients with the ASM syndrome, divided into groups
according to the etiology of the disease (” „ SD)
Intensity of the ITS of C3c and C4 is shown in Fig. 4 (”
and SD). All groups had the higher mean value of C4I then
C3cI. A slight increase of the mean values of C3cI from
MNG, over the ENTERO to SM group was shown. On the
contrary, the mean values of C4I gradually fell in the same
way. The lowest mean values of C3cI and C4I were in TBC
group, which reached the statistical significance for C3cI
(p<0.05) with reference to ENTERO and SM, and for C4I
with reference to MNG and ENTERO.
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Table 1
Frequency of the intrathecal synthesis C3c and C4 in the patients with the
ASM syndrome, proven with the CSF indexes
C3c
n (%)
C4
n (%)
C3c + C4
n (%)
Total C3c and/or C4
n (%)
MNG
n=32 2 (6.3)* 2 (6.3) 3 (9.4) 7 (21.9)
ENTERO
n=120 10 (8.3) 8 (6.7) 7 (5.8) 25 (20.8)
SM
n=44 4 (9.1) 4 (9.1) 3 (6.8) 11 (25.0)
TBC
n=14 − 2 (14.3) 2 (14.3) 4 (28.6)
Total 210 16 (7.6) 16 (7.6) 15 (7.1) 47 (22.4)
* ”, (SD)Strana 268 VOJNOSANITETSKI PREGLED Broj 3
Intensity of the ITS of IgG is shown in Fig. 5 (” and
SD). The highest mean value of IgGI was found in TBC
group, which was statistically significant in reference to the
other groups of patients (p<0.05).
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Fig. 5 − Intrathecal synthesis of IgG in the patients with the
ASM syndrome, divided into groups according to the etiology
of the disease, proven with the CSF indexes (” „ SD)
The positive correlation between IgGI and C3cI
(r  =  0.45, p<0.01) and a little lesser positive correlation
between IgGI and C4I (r = 0.19, p<0.05), and also positive
correlation between C3cI and C4I (r = 0.45, p<0.01) was
found in ENTERO group. In TBC group, there was neither
correlation between IgGI and C3c (r = -0.40), nor between
C3cI and C4 (r = -0.09)
Discussion
Some anatomical and ultrastructural characteristics of
the CNS − the unique cellular environment, contributed to
the observed differences in immunological function be-
tween the CNS and other organs (9). The low, nonconsti-
tute expression of the major histocompatibility complex
molecules, the low concentrations of antibodies and pro-
teins of complement were the cause of the relative immu-
nological brain isolation, respectively implying a suppres-
sive environment for immune reactivity in this organ, so the
one of the main questions was the mode for starting the in-
flammation in the CNS, especially when the BBB is intact
(10). It was found that complement-derived polypeptide
C3adesArg increased the permeability of BBB and pro-
duced an accumulation of leucocytes in the CSF when in-
jected into the cisterna magna or intraventricularly. This
peptide acted as a mediator of inflammation in the CNS
(11, 12). The complement system could be one of the im-
portant elements of the brain primary defense from infec-
tions, especially in the early stage, when the specific anti-
bodies were not yet created. It was not only the alternative
pathway of complement activation, like evolutionary an-
cient defense system against infections which could be acti-
vated without the antibodies, but also the classical pathway
and could also be activated very early, even before the ap-
pearance of antibodies by other factors such as trypsin-like
enzymes, myelin and vira, as well (13).
Some author's considerations that the specific identifi-
cation of complement factors in CSF promised to be diag-
nostic not only for complement activation but also for the
mode of activation, i.e., the nature of the activator (5), in-
cited us to test it by determination of C3c and C4 in the
CSF of patients with the CNS infection with the signs of
ASM syndrome.
The abnormal complement values were found in both
serum and CSF in the examined patient groups. Signifi-
cantly higher values of C4 and significantly lower of C3c
(except in the ENTERO group) in serum, could demon-
strate the strong activation of the main complement path-
way in serum of the patients with the ASM syndrome, with
probable simultaneous increase of C3 consumption. Be-
tween the groups there were no significant differences in
concentrations of this two complement proteins in serum.
In the patients with similar etiology, Trbojevi}-^epe (5)
found significantly higher concentrations both in C3c and
C4 sera, in reference to the control group.
Most of the complement proteins present in the serum
are synthesized by hepatocytes and mononuclear phago-
cytes, but some other cell types, like epithelial and endo-
thelial cells, have this ability, too. Like immunoglobulins,
the complement proteins traverse BBB by mechanism of
diffusion, so their concentrations in CSF depend upon the
concentration in serum. The higher CSF/serum concentra-
tion ratio (Q) for C4, compared to QC3c, not only in ex-
amined patients but also in the control group, could be ex-
plained by additional ITS of C4. In contrast to immuno-
globulins which ITS was found only in the pathological
conditions (in the inflammatory diseases of CNS, and ma-
lignant CNS tumors) (14), this findings pointed out that
ITS of C4 was most probably continuously present in the
normal brain. This could be supported by other studies in
which the production of two proteins of the alternative
pathway of complement activation (C3 and factor B) in
primary cultures of mouse astroglial cells (15), some pro-
teins of the main pathway (C1q, C3 and C4) in normal and
pathological human postmortem brain tissues (16) were re-
ported, and Gasque, et al (17−19) found that astrocytes
could synthesize a complete, functional complement system
under appropriate cytokine drive,.
Significantly lower values of QC3c and QC4 in pa-
tients with meningismus with respect to the control group
were the consequence of significantly lower QAlb values,
i.e., the patients younger than the control group. The grad-
ual increase of the quotients of this two complement pro-
teins from MNG, over the ENTERO and SM to TBC
group, entirely followed the increase of QAlb , i.e., the
height of the quotients depended upon the degree of the
BBB permeability, which was approved with the highly
positive correlation found between QAlb and QC3c and
QC4 in patients in whom ITS of this two complement pro-
teins was not proved.
Thus, in patients with the infection of CNS the ele-
vated concentrations of C3c and C4 in CSF, i.e., the ele-Broj 3 VOJNOSANITETSKI PREGLED Strana 269
vated values of QC3c and QC4, were the consequence of
the increased permeability of the BBB and/or ITS, where
this two proteins could be synthesized by mono-
cite/makrophages, which could traverse the BBB from cir-
culation and also some cellular types inside the brain, par-
ticularly astrocytes.
In the examined patients not only the total frequency
of ITS of C3c and C4 was almost equal in all groups, but
there also was almost identical frequency of ITS only C3c,
and only C4, and at the same time both of this two pro-
teins were found not only in examined groups, but in-
between every particularly group. It pointed out that both
ways of complement activation, a classical and alternative
one, were equally represented, in relation to various eti-
ology of the disease. Yet, differences between groups
were present when the intensity of ITS was observed. A
significantly lower intensity of ITS, and both C3c and C4
in the TBC group related to the other groups was an un-
expected finding. The groups were arranged by the height
of the middle values of examined protein parameters, and
completely corresponded with the clinical picture and the
rate of path anatomical changes in CNS during these in-
fections. Alb quotients, QC3c and QC4, but also ITS IgG
were highest in the TBC group which was expected, be-
cause it was very serious CNS infection in which there was
surely an intensive activation of both complement path-
ways, and also an intensive immunological response and
consequently a heavy inflammatory response of the CNS.
It seemed that the explanation of this finding should be
sought for in the phase of the disease. The examination
was conducted in the acute phase and this was in average
during the first 72 hours from the appearance of clinical
symptoms of CNS irritation in the MNG and ENTERO
groups, (in SM group it was the fourth day, and in the
TBC the tenth day). TBC meningitis is a disease that
starts slowly and unobtrusively, with nonspecific symp-
toms, so the beginning of this disease is very hard to de-
termine. By the time the symptoms of CNS infection were
clear enough, the disease was in high progression, so the
information about the duration of the condition and the
obtaining of material for analysis was not reliable. Thus, a
significantly higher ITS of these two proteins of comple-
ment in MNG, ENTERO and SM referred to the TBC
group was most probably the reflection of an early phase
of disease in which there was the most intensive activation
of the complement system, in distinction from the TBC
meningitis where the lower values are the result of grad-
ual reduction of complement activation in the later
phases of the disease. In behalf of such explanation there
was the research of Stahl, et al (20) who, studding ITS of
the complement protein of the alternative pathway of ac-
tivation in the brain of mice with Lysteria monocytogenes
meningitis, found a higher expression of C3 and mRNA
factor B in the pyramidal neurons and Purkinje's cells
within 6 hours, with maximum within 12 hours, and after
that period they registered gradual fall of this expression
within the next 72 hours after the infection.
The results of this research confirmed the findings of
other authors that the CSF index was a very good method
for detection of ITS C3 and C4 (3−5, 21). The determina-
tion of ITS C3c and C4 was not of great help in differential
diagnosis of patients with syndrome of ASM. Remarkable
was the displayed difference in intensity of ITS C3c and C4
between the TBC and the other groups, which might be
able to refer to the phase of the disease under the condition
to simultaneously examine the intensity of ITS IgG, which
should be confirmed by further examination of the dynamic
of ITS C3c and C4 in CNS infections.
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INTRATEKALNA SINTEZA KOMPONENTI KOMPLEMENTA C3c I C4 U
INFEKCIJAMA CENTRALNOG NERVNOG SISTEMA KOJE SE MANIFESTUJU
SINDROMOM AKUTNOG SEROZNOG MENINGITISA
Kod 210 bolesnika s meningizmom i infekcijama centralnog nervnog sistema koje
se manifestuju sindromom akutnog seroznog meningitisa (ASM), podeljenih u
grupe na temelju etiologije (enterovirusni meningitis-ENTERO, serozni meningitis
rezli~ite etiologije-SM i tuberkulozni meningitis-TBC) odre|ena je intratekalna sin-
teza (ITS) komponenti komplementa C3c i C4 (kao i IgG) metodom likvorskih
indeksa (I), da bi se istra`ila njihova uloga u diferencijalnoj dijagnozi ovoga sin-
droma. Ura|ena je korelativna studija izme|u albuminskih kvocijenata (QAlb) i
QC3c i QC4 kod bolesnika kod kojih nije dokazana ITS ova dva proteina komple-
menta, kao i komparativna studija povi{enih vrednosti C3cI i C4I (kao i IgGI)
izme|u ispitivaih grupa bolesnika. Na|ena je statisti~ki visoko zna~ajna korelacija
izme|u QAlb i QC3c (r = 0,89, p<0,001) i QC4 (r = 0,85, p<0,001). ITS C3c i C4
na|ena je ukupno u 22,4% ispitivanih bolesnika. Nije na|ena razlika u u~estalosti
ITS ova dva proteina komplementa izme|u ispitivanih grupa, niti unutar pojedine
grupe. Na|en je statisti~ki zna~ajno ni`i intenzitet ITS C3c i C4 u TBC grupi
(p<0,05) i to u odnosu na ENTERO i SM za C3c, na MNG i ENTERO za C4, a
zna~ajno vi{i intenzitet ITS IgG (p<0,05) u odnosu na ostale ispitivane grupe.
Likvorski indeks je veoma dobra metoda za detekciju ITS C3c i C4. Odre|ivanje
ITS C3c i C4 ne mo`e biti od ve}e pomo}i u diferencijalnoj dijagnozi bolesnika sa
sindromom ASM. Intenzitet ITS C3c i C4, ukoliko se stavi u odnos sa intenzitetom
ITS IgG, mo`da bi mogao govoriti o fazi bolesti.
K lj u ~ n e   r e ~ i :  meningitis; meningizam; cerebrospinalna te~nost;
cerebrospinalna te~nost, proteini; komplementi; IGG;
dijagnoza, differencijalna.